Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial.

Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E, Hanna A.

Diabetes Care. 2007 Nov;30(11):2804-10. Epub 2007 Aug 8.

PMID:
17686832
2.

Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes.

Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL.

Diabetes Care. 2002 Oct;25(10):1709-14.

PMID:
12351466
3.

Reduction in postprandial glucose excursion and prolongation of satiety: possible explanation of the long-term effects of whole grain Salba (Salvia Hispanica L.).

Vuksan V, Jenkins AL, Dias AG, Lee AS, Jovanovski E, Rogovik AL, Hanna A.

Eur J Clin Nutr. 2010 Apr;64(4):436-8. doi: 10.1038/ejcn.2009.159. Epub 2010 Jan 20.

PMID:
20087375
4.

Chia seed does not promote weight loss or alter disease risk factors in overweight adults.

Nieman DC, Cayea EJ, Austin MD, Henson DA, McAnulty SR, Jin F.

Nutr Res. 2009 Jun;29(6):414-8. doi: 10.1016/j.nutres.2009.05.011.

PMID:
19628108
5.

Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes.

Jenkins DJ, Kendall CW, Augustin LS, Martini MC, Axelsen M, Faulkner D, Vidgen E, Parker T, Lau H, Connelly PW, Teitel J, Singer W, Vandenbroucke AC, Leiter LA, Josse RG.

Diabetes Care. 2002 Sep;25(9):1522-8.

PMID:
12196421
6.

A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects.

Cugnet-Anceau C, Nazare JA, Biorklund M, Le Coquil E, Sassolas A, Sothier M, Holm J, Landin-Olsson M, Onning G, Laville M, Moulin P.

Br J Nutr. 2010 Feb;103(3):422-8. doi: 10.1017/S0007114509991875. Epub 2009 Sep 28.

PMID:
19781120
7.

Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects.

Hermansen K, Søndergaard M, Høie L, Carstensen M, Brock B.

Diabetes Care. 2001 Feb;24(2):228-33.

PMID:
11213870
8.
9.

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, Henderson W; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2.

J Diabetes Complications. 2003 Nov-Dec;17(6):314-22.

PMID:
14583175
10.

Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM.

Hanefeld M, Fischer S, Schmechel H, Rothe G, Schulze J, Dude H, Schwanebeck U, Julius U.

Diabetes Care. 1991 Apr;14(4):308-17.

PMID:
2060433
11.

Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus.

Avilés-Santa L, Salinas K, Adams-Huet B, Raskin P.

J Investig Med. 2006 Jan;54(1):20-31.

PMID:
16409887
13.

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.

Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Wintle ME, Maggs DG.

Curr Med Res Opin. 2008 Jan;24(1):275-86.

PMID:
18053320
14.

Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report.

Abraira C, Duckworth WC, Moritz T; VADT Group.

Diabetes Obes Metab. 2009 Feb;11(2):150-6. doi: 10.1111/j.1463-1326.2008.00933.x. Epub 2008 Jul 29.

PMID:
18671796
15.

Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.

Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM.

Circulation. 2005 May 17;111(19):2446-53. Epub 2005 May 2.

16.

Impact of physical activity on cardiovascular risk factors in IDDM.

Lehmann R, Kaplan V, Bingisser R, Bloch KE, Spinas GA.

Diabetes Care. 1997 Oct;20(10):1603-11.

PMID:
9314643
17.

The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.

Madsen T, Schmidt EB, Christensen JH.

J Ren Nutr. 2007 Jul;17(4):258-63.

PMID:
17586424
18.

Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes.

Scott AR, Dhindsa P, Forsyth J, Mansell P; Kliofem Study Collaborative Group.

Diabetes Obes Metab. 2004 Jan;6(1):16-22.

PMID:
14686958
20.

Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes.

Gouni-Berthold I, Berthold HK, Mantzoros CS, Böhm M, Krone W.

Diabetes Care. 2008 Jul;31(7):1389-91. doi: 10.2337/dc08-0194. Epub 2008 Mar 28.

Supplemental Content

Support Center